• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Malaria.com

Anti-Infective Drugs Market to Reach $66 Billion by 2013, Says Report

October 15, 2010 By Malaria.com Leave a Comment

The anti-infective drugs market will jump to $66 billion by 2013, according to a recently published report. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Six infectious diseases -- pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS -- account for half of all premature deaths worldwide. … [Read more...]

Filed Under: Malaria News Tagged With: Abraxis Bioscience, Acambis, Achillion, Acute Suppurative Thyroiditis, Adlyfe, Advanced Life Sciences Holdings, Affinium, Akonni Biosystems, Alnylam, Anti-fungal Agents, Anti-Infective Drugs, Anti-viral Therapeutics, Antibiotics, APP, Aquapharm Biodiscovery, Arbor Vita, Arpida, Avexa, Avian Bird Flu, Basilea, Baxter, Biophage Pharma, Blood-Borne Infections, CEL-SCI, Cerexa, Combimatrix, Complicated Skin and Skin Structure Infections, cSSSI, Cubist, Daiichi Sankyo, Diarrhea, Hospira, Idenix, Incyte, Influenza, Lymphadenitis, Malaria, Measles, Medivir, Meiji Holdings, MerLion, Mutabilis, Nanobio, Nanosphere, Nanoviricides, Novabay, Obetech, Optimer, Panacos, Pancreatitis, Paratek, Pharmasset, Pharyngotonsillitis, Pico, Pneumonia, Polymedix, Powdermed, Presidio, Progenics, Prophylactic Treatments, Protez, Reye's Syndrome, Rib-X, Ribomed, Sinusitis, Targanta, Theravance, Trius, Tuberculosis, Urinary Tract Infections, UTI, Vascular Infections, Vertex, Viral Encephalitis, West Nile Virus, X-GEN

Research Leads to Promising Malaria Drug Candidate

September 20, 2010 By Malaria.com Leave a Comment

A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers including Elizabeth A. Winzeler, Ph.D., a grantee of the National Institute of Allergy and Infectious Diseases (NIAID), part … [Read more...]

Filed Under: Malaria News Tagged With: Anthony S. Fauci, artemisinins, Elizabeth A. Winzeler, Genomic Institute of the Novartis Research Foundation, Malaria Drugs, National Institutes of Health, NIH, NITD609, Novartis Institute for Tropical Diseases (NITD), Plasmodium Falciparum, Scripps Research Institute, Thierry T. Diagana

Anopheles Mosquitoes

September 13, 2010 By Malaria.com Leave a Comment

Anopheles Mosquitoes Diagram of Adult Female Mosquito   Malaria is transmitted among humans by female mosquitoes of the genus Anopheles. Female mosquitoes take blood meals to carry out egg production, and such blood meals are the link between the human and the mosquito hosts in the parasite life cycle. The successful development of the malaria parasite in the mosquito … [Read more...]

Filed Under: Malaria Overview Tagged With: Anopheles Mosquitoes

NITD609 Compound May Be Promising Malaria Drug Candidate, Say Researchers

September 3, 2010 By Malaria.com Leave a Comment

A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers. “Although significant progress has been made in controlling malaria, the disease still kills nearly 1 million people every … [Read more...]

Filed Under: Malaria News, Malaria Research Tagged With: Anthony S. Fauci, Artemisinin, Elizabeth A. Winzeler, NITD609, Plasmodium Falciparum, Spiroindolones, Thierry T. Diagana

Screening Mosquito House Entry Points as a Potential Method for Integrated Control of Malaria

August 3, 2010 By Malaria.com 1 Comment

Partial mosquito-proofing of houses with screens and ceilings has the potential to reduce indoor densities of malaria mosquitoes. We wish to measure whether it will also reduce indoor densities of vectors of neglected tropical diseases. Methodology: The main house entry points preferred by anopheline and culicine vectors were determined through controlled experiments using specially … [Read more...]

Filed Under: Transmission & Vectors Tagged With: Addessium Foundation, Anopheline Vectors, Arbovirus, CDC, Chikungunya, Culex, Culicine Vectors, Endophagic Filariasis, Endophagic Mosquitoes, O'Nyong Nyong, Research Career Development Fellowship, Rift Valley Fever, Screening, Tanzania, U.S. President's Malaria Initiative, Valent Bioscience Corporation

The Effects of Maternal Helminth and Malaria Infections on Mother-to-Child HIV Transmission

November 4, 2005 By Malaria.com Leave a Comment

Objective: To investigate the effect of helminth and/or malaria infection on the risk of HIV infection in pregnant women and its transmission to their offspring. Design: A retrospective cohort study of pregnant Kenyan women and their offspring from term, uncomplicated vaginal deliveries (n = 936) with a nested case-control study. Methods: We determined the presence of HIV, malaria, … [Read more...]

Filed Under: Malaria Research Tagged With: Helminths, HIV, Kenya, Lymphatic Filariasis, Schistosomiasis

« Previous Page

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

Five Things You Might Not Know About Medicine Quality

The proliferation of poor quality medicines has been described as a global pandemic that threatens the lives of millions.1 It stands to reason that poor quality medicines are not going to improve anyone’s health, but how much do we really know about the quality of medicines used across the world? Here we examine five issues relating to medicine quality in an effort to show why we should all be paying more attention to a serious public health issue that is difficult to tackle and not yet fully understood.

How Can We Detect Poor Quality Medicines?

Finding out what medicines contain and investigating their packaging are vital steps in the fight against poor quality medicines, both substandard and falsified. Falsified medicines usually masquerade as real medicines by copying the appearance and packaging of the real product, but may not contain any of the same active ingredients, or in the correct amounts.

Challenges in Tackling the Issue of Poor Quality Medicines

There are many unresolved issues that impede the elimination of poor quality medicines, namely: (1) Progress impeded by confusion over definitions; Ensuring a market free of poor quality medicines; and the lack of global criminal laws.

Editorial

Antimicrobial Resistance: The Silent Threat in Malaria Eradication

By Bernard Owusu Agyware, Arielle Dolegui and Jesus Aquilar Malaria is a serious and sometimes deadly disease, affecting millions and claiming more than  600,000 lives worldwide each year in 2022 and 2021.1 Low and Middle-Income Countries (LMICs), particularly in Sub-Saharan Africa, disproportionately bear the greatest burden of malaria. The fight to eradicate this worrisome disease […]

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2026 Malaria.com · Log in